TickerGuard
Buy Day today: Neutral (58) Mixed market breadth · no major macro event
MDRX

Veradigm Inc.

Healthcare · Health Information Services

5.00$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios MDRX
Line item Q1 14 Q2 14 Q3 14 Q4 14 Q1 15 Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 24
Valuation
– – – 37.2 69.3 242.1 – – 257.3 844.2 – – – – – – – 994.7 – 4.6 4.1 10.7 8.7 – – – – 3.1 2.9 3.3 2.1 16.5 17.6 28.2 35.3 – – – – –
2.4 2.1 1.7 1.7 1.6 1.8 1.7 2.1 1.8 1.7 1.7 1.2 1.4 1.4 1.5 1.5 1.2 1.1 1.2 1.0 1.0 1.2 1.2 0.9 0.6 0.6 0.8 1.4 1.4 1.8 1.2 1.5 2.0 1.7 2.3 – – – – –
2.5 2.2 1.9 1.8 1.7 1.8 1.7 2.1 1.8 1.8 1.8 1.5 2.0 2.1 2.3 2.4 2.1 1.9 2.3 1.1 1.1 1.5 1.4 1.3 0.9 0.9 1.1 1.3 1.3 1.8 1.2 1.6 1.9 1.5 1.7 – – – – –
2.7 2.4 2.1 2.1 1.9 2.2 2.1 2.5 2.2 2.1 2.1 1.6 1.8 1.8 1.9 1.9 1.7 1.5 1.6 1.2 1.4 1.7 1.8 1.4 1.2 1.2 1.3 1.2 1.2 1.9 1.3 1.6 2.3 1.4 2.0 – – – – –
59.1 37.8 26.9 21.1 19.0 20.2 16.5 18.1 15.3 14.3 14.0 11.5 12.4 27.4 30.3 35.6 45.9 10.4 12.1 11.3 10.5 – – 36.5 57.3 12.9 17.1 116.4 150.7 102.7 47.7 8.7 10.7 6.2 7.4 – – – – –
– – – 63.3 27.3 27.3 20.4 20.5 16.4 14.4 16.1 14.2 21.8 35.4 38.3 28.0 24.3 28.1 55.7 – – – – – – – – – – – – – – 12.6 17.1 – – – – –
-1.6% -0.6% -0.3% 1.6% 3.7% 3.7% 4.9% 4.9% 6.1% 7.0% 6.2% 7.0% 4.6% 2.8% 2.6% 3.6% 4.1% 3.6% 1.8% -3.2% -6.6% -6.0% -5.2% -5.2% -7.9% -4.9% -2.0% -9.4% -8.4% -15.1% -22.0% -5.5% -2.2% 7.9% 5.8% – – – – –
Margins
39.4% 39.5% 39.5% 39.6% 39.2% 39.4% 40.8% 41.9% 43.1% 43.7% 43.4% 43.3% 43.1% 43.4% 44.0% 43.3% 45.5% 46.8% 48.3% 49.3% 46.3% 44.0% 40.2% 40.3% 40.2% 40.6% 41.4% 39.7% 39.0% 37.5% 47.2% 49.3% 53.0% 58.4% 48.4% – – – – –
-8.1% -6.7% -4.9% -2.8% -2.4% -1.3% 0.7% 2.3% 3.5% 4.4% 4.8% 3.9% 3.7% 3.7% 4.1% 2.3% 1.3% -2.9% -3.9% -5.5% -5.2% -1.4% -1.4% -1.4% -3.1% -4.9% -5.8% -13.7% -11.8% -9.1% -7.2% 5.6% 6.5% 5.8% 8.1% – – – – –
-6.7% -1.6% -3.2% 4.5% 2.3% 0.7% -1.5% -0.2% 0.7% 0.2% -0.1% -2.8% -4.1% -12.6% -13.3% -10.9% -11.3% 0.1% -0.3% 20.8% 23.7% 11.4% 14.0% -10.3% -11.1% -3.1% -2.7% 46.7% 50.3% 53.5% 55.8% 8.9% 11.6% 5.9% 6.6% – – – – –
-3.7% -1.3% -0.6% 2.6% 5.8% 6.6% 8.3% 10.4% 11.0% 11.5% 10.4% 8.5% 6.5% 4.0% 3.9% 5.2% 4.8% 3.8% 2.2% -3.1% -6.4% -7.3% -6.4% -4.7% -5.1% -3.2% -1.5% -13.6% -12.1% -26.8% -26.3% -8.1% -4.6% 13.2% 13.7% – – – – –
Returns
-7.0% -1.7% -3.5% 4.8% 2.4% 0.7% -1.5% -0.2% 0.7% 0.2% -0.2% -3.6% -5.8% -18.6% -20.6% -17.5% -20.2% 0.2% -0.5% 23.4% 27.2% 13.8% 16.5% -14.2% -15.7% -4.2% -3.7% 42.1% 43.6% 54.6% 54.6% 9.5% 11.0% 5.2% 4.7% – – – – –
-3.5% -0.8% -1.7% 2.5% 1.2% 0.4% -0.8% -0.1% 0.4% 0.1% -0.1% -1.1% -1.7% -5.5% -5.9% -4.6% -5.0% 0.0% -0.1% 11.4% 12.2% 5.6% 6.5% -5.7% -6.0% -1.7% -1.4% 24.1% 25.5% 30.0% 31.2% 5.5% 6.1% 3.6% 3.3% – – – – –
Balance Sheet & Debt
507 436 550 523 484 586 564 509 500 581 609 658 647 688 687 795 971 889 923 494 674 755 833 808 891 881 878 -341 -321 212 178 187 306 -294 -286 – – – – –
8.0 4.9 5.0 3.9 3.5 3.8 3.2 2.7 2.5 2.8 2.8 3.0 2.7 6.3 6.4 8.2 13.9 3.0 3.3 2.6 3.1 – – 12.2 25.1 5.7 6.9 -21.7 -27.2 7.9 4.6 0.7 1.1 -1.3 -1.3 – – – – –
49.6% 50.1% 49.9% 52.1% 51.0% 51.1% 51.8% 52.5% 52.5% 36.1% 34.9% 32.2% 30.2% 29.7% 28.5% 26.5% 24.5% 25.6% 24.1% 48.8% 44.9% 40.7% 39.7% 40.1% 38.2% 39.0% 38.4% 57.1% 58.5% 54.9% 57.1% 58.1% 55.7% 69.8% 69.6% – – – – –
0.4 0.4 0.5 0.4 0.4 0.5 0.5 0.4 0.4 0.5 0.5 0.6 0.7 0.7 0.7 0.8 1.0 0.9 1.0 0.4 0.6 0.7 0.8 0.7 0.9 0.9 0.9 0.1 0.1 0.3 0.3 0.3 0.3 0.2 0.2 – – – – –
Per Share
-0.51 -0.12 -0.25 0.34 0.17 0.06 -0.11 -0.01 0.05 0.02 -0.01 -0.24 -0.37 -1.16 -1.26 -1.09 -1.20 0.01 -0.03 2.07 2.33 1.09 1.27 -1.11 -1.20 -0.32 -0.28 4.66 5.22 5.57 6.26 1.12 1.28 0.52 0.43 – – – – –
7.63 7.63 7.70 7.64 7.60 7.56 7.31 7.24 7.33 7.67 7.89 8.46 8.95 9.15 9.49 9.99 10.60 11.19 11.91 9.98 9.81 9.53 9.07 10.78 10.81 10.56 10.40 9.96 10.37 10.41 11.21 12.51 11.02 8.88 6.49 – – – – –
7.30 7.23 7.12 7.12 7.08 7.61 7.33 7.35 7.22 7.17 7.14 6.73 6.35 6.21 6.12 6.20 5.96 6.20 6.23 8.84 8.57 7.91 7.70 7.82 7.64 7.64 7.50 11.05 11.97 10.20 11.45 11.72 11.68 10.08 9.13 – – – – –
-0.28 -0.10 -0.04 0.20 0.44 0.50 0.61 0.75 0.81 0.88 0.82 0.72 0.58 0.36 0.37 0.52 0.51 0.43 0.26 -0.31 -0.62 -0.69 -0.58 -0.51 -0.55 -0.33 -0.16 -1.36 -1.25 -2.79 -2.95 -1.01 -0.50 1.18 0.89 – – – – –

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?